GLG Partners’s Bristol-Myers Squibb BMY Stock Holding History

GLG Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-10,000	Closed	-$639K	–	430
2016 Q1	$639K	Buy	+10,000	New	+$631K	0.02%	349
2015 Q4	–	Sell	-44,654	Closed	-$2.64M	–	462
2015 Q3	$2.64M	Buy	44,654 +2,125	+5%	+$135K	0.07%	257
2015 Q2	$2.83M	Buy	42,529 +13,756	+48%	+$907K	0.07%	260
2015 Q1	$1.86M	Sell	28,773 -5,047	-15%	-$316K	0.06%	249
2014 Q4	$2M	Buy	+33,820	New	+$1.91M	0.06%	244
2014 Q2	–	Sell	-41,400	Closed	-$2.15M	–	372
2014 Q1	$2.15M	Buy	+41,400	New	+$2.2M	0.04%	257

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GLG Partners's BMY Position: Q2 2016 in Review

GLG Partners sold out of Bristol-Myers Squibb (BMY) in Q2 2016, closing a stake of 10,000 shares — an estimated $639K sold.

GLG Partners first reported a position in BMY in Q1 2014 and held it in 6 quarters. The position peaked at $2.83M in Q2 2015. 1,577 funds tracked by Wall St. Rank hold BMY as of Q2 2016.

GLG Partners reported no remaining Bristol-Myers Squibb position as of Q2 2016 after selling out during the quarter.
GLG Partners sold 10,000 Bristol-Myers Squibb shares in Q2 2016, an estimated $639K.
GLG Partners first reported a position in Bristol-Myers Squibb in Q1 2014 and held it in 6 quarters.
GLG Partners's Bristol-Myers Squibb position peaked at $2.83M in Q2 2015.
1,577 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2016.

Based on GLG Partners's 13F filing for Q2 2016, filed 16 Aug 2016.